For instance, in papillary thyroid carcinoma (PTC), the combined stimulation of IFN-γ and TNF-α can significantly synergistically upregulate the expression of CXCL9 and CXCL11, activating the anti-tumor immune pathway (92). This evidence concerns the gene TNF and neoplasm.